NIDCR COVID-19 Funding Opportunities

NIDCR is funding research into COVID-19. Dena Fischer, DDS, MSD, MS, NIDCR's Director of the Center for Clinical Research, explains the different funding mechanisms currently available to the research community. If you wish to only view a particular question and answer, follow the links below the video:

Current Funding Opportunities

Previous Funding Opportunities

Title Staff Contact Opportunity Number Activity Code First Application Due Date
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) PAR-20-243 R01

03/02/2021

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project Jason Wan, PhD
(301) 594-9898
NOT-OD-20-129 multiple, see announcement

03/12/2021

07/12/2021

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations Elise Rice, PhD
(301) 594-4814
NOT-OD-20-119 multiple, see announcement 7/08/2020
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations Elise Rice, PhD
(301) 594-4814
NOT-OD-20-120 multiple, see announcement 7/08/2020
Notice of NIDCR's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)" NOT-DE-20-030 N/A N/A
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-121 multiple, see announcement 8/07/2020
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) Dorothy Castille
(301) 594-9411
RFA-OD-20-013 U24 8/07/2020
NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)

Lillian Shum, PhD

(301) 204-0908
RFA-RM-20-021 DP5 9/04/2020
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool Amanda Melillo, PhD
(301) 312-9037
NOT-OD-20-152 Admin Supp 9/15/2020
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) Amanda Melillo, PhD
(301) 312-9037
RFA-OD-20-022 U01 9/15/2020
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) Orlando Lopez, PhD
(301) 402-4243
RFA-OD-20-017 U18 9/18/2020
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) Preethi Chander, PhD
(301) 827-4620
RFA-OD-20-018 U18 9/18/2020
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

Orlando Lopez, PhD
(301) 402-4243

RFA-OD-20-021 R42 9/18/2020
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) Orlando Lopez, PhD
(301) 402-4243
RFA-OD-20-020 R44 9/18/2020
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) Lillian Shum, PhD
(301) 204-0908
RFA-RM-20-020 R01 9/30/2020
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Dena Fischer, DDS, MSD, MS

(301) 594-4876

RFA-OD-20-016 R01 9/30/2020
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) Amanda Melillo, PhD
(301) 312-9037
RFA-OD-20-019 U24 10/01/2020
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR Dena Fischer, DDS, MSD, MS

(301) 594-4876

Preethi Chander, PhD
(301) 827-4620

Lynn King, PhD
(301) 594-5006

NOT-DE-20-022 multiple, see announcement 11/02/2020
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network Dena Fischer, DDS, MSD, MS

(301) 594-4876

NOT-DE-20-023 multiple, see announcement 11/02/2020
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) PAR-20-237 R01

12/01/2020

 

Last Reviewed
August 2020